-
Uncategorized2 months ago
White House policies are ‘incredibly worrisome’ for small biotechs, Rhythm CEO says
Biotechs with single products in the market are likely on edge about how President Donald Trump’s pharma tariffs and “most favored nation” pricing will play out,...
-
Uncategorized2 months agoSTAT+: Access granted: CMS greenlights more than 150 participants for chronic care experiment
More than 150 companies and providers have been provisionally approved to participate in an experimental Medicare program meant to expand access to technology-supported chronic care. They...
-
Uncategorized2 months ago
FDA narrows in on search for new biologics and vaccines leader
The FDA is getting closer to announcing a director of the Center for Biologics Evaluation and Research, sources told Endpoints News, following the controversial tenure of...
-
Uncategorized2 months agoSpyre drug for inflammatory bowel disease shows promise in early study
The therapy, which works similarly to Takeda’s blockbuster Entyvio, showed remission rates that suggest a “best-in-class” profile, the company said.
-
Uncategorized2 months agoRevolution pancreatic cancer drug nearly doubles survival in key trial
The subject of buyout rumors this year, Revolution posted Phase 3 results one analyst called a “game changer” in a tough-to-treat tumor. Read More
-
Uncategorized2 months ago
Allogene’s first cut of data on ‘off-the-shelf’ CAR-T shows promise
Allogene Therapeutics’ CAR-T therapy removed all remaining detectable lymphoma cells in just over half of treated patients, according to an early look at the Phase 2...
-
Uncategorized2 months ago
Regeneron wades into radiopharma through $40M upfront deal with Telix
Regeneron is set to work on radiopharmaceuticals for the first time in a new partnership to develop solid tumor therapies as well as diagnostic agents with...
-
Uncategorized2 months ago
Neural Mechanism Underlying Sensory Behavior Revealed in C. elegans
Animal behavior reflects a complex interplay between an animal’s brain and its sensory surroundings. In a new study published in Nature Neuroscience titled, “Neural sequences underlying directed turning in Caenorhabditis elegans,”...
-
Uncategorized2 months ago
FDA urges clinical trial sponsors to report the results of their studies
An FDA review of records found that results have not been reported for 30% of registered clinical studies. To remedy this shortfall, the U.S. regulator has...
-
Uncategorized2 months agoReAlta secures $40m to advance peptide for newborn brain injury
ReAlta Life Sciences has announced the closing of an oversubscribed $40 million financing, bringing the total capital raised to date to more than $150 million. The...
